C. B. Gilks

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)

C. Gilks, M. Tsao, C. Cheung, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1 Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers

Clive R. Taylor, Jacqueline A. Hall, A. Marchetti, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.

Keith Miller, Clive R Taylor, Manfred Dietel, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.

S. Kalloger, E. Torlakovic, John Garratt, 2014, Archives of pathology & laboratory medicine.